Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Cell Metabolism of groundbreaking preclinical data demonstrating ...

Researchers developed a way to directly reprogram human glial cells into PV interneurons without passing through a stem‑cell stage.

Scientists at Stanford Medicine have reported a discovery that could change how arthritis and joint damage are treated. In ...

Congress has unveiled a new package of bills to fund some agencies through fiscal 2026, the latest bipartisan breakthrough as ...

Alzheimer’s may advance by breaking the brain’s internal clock—and resetting it could help fight the disease. Alzheimer’s disease often interferes with a person’s normal daily patterns. Early warning ...

Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...

Researchers at Lund University in Sweden have created a method that makes it possible to transform the brain’s support cells ...

ME Therapeutics Holdings Inc. (“ME Therapeutics” or the “Company”) (CSE: METX) (FSE: Q9T), a publicly listed biotechnology company discovering and developing novel drugs to reprogram the immune ...

Commission took multiple actions during its Dec. 31 meeting, including approving payment for a third-party forensic auditor ...

Clonell launches the world’s first patient-specific embryonic stem cell therapy platform, aimed at incurable diseases with ...

Blue Falcon and Dynomutt #5 hits stores Wednesday! The dynamic duo faces their climactic finale as chaos threatens Big City.

Many organisms have an amazing capacity to adapt to conditions of low oxygen, but the cellular mechanisms of this are poorly understood. A new study in mice has unveiled a molecular trigger that ...